<DOC>
	<DOC>NCT00223041</DOC>
	<brief_summary>Cardiovascular disease after renal transplantation is an important problem. Patients after renal transplantation with low LDL-Levels (&lt;130mg/dl) receive Fluvastatin 80mg/day (or no medication, to look for the cardiovascular outcome with and without statins.</brief_summary>
	<brief_title>Cranoc Lipid Study in Renal Transplantation</brief_title>
	<detailed_description>Cardiovascular disease after renal transplantation is an important problem. Patients after renal transplantation with low LDL-Levels (&lt;130mg/dl) receive Fluvastatin 80mg/day (or no medication, to look for the cardiovascular outcome with and without statins.</detailed_description>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>patients (18 65, inclusive) cadaver and living kidney transplantation (1. Ntx, 2. Ntx) LDLcholesterol ≤ 130mg/dl (3 Mo until start of Tx) Patients with a history of Myocard infarct: LDLCholesterol ≤ 110mg/dl Immunsuppression: Tacrolimus in combination with steroids or Mycophenolat Mofetil patients indulgence statin before the study LDLCholesterol &gt;130mg/dl before transplantation Instabil Angina, Myocard infarct &lt;6 months before transplantation symptomatic Hypothyreosis child bearing, lactating elavated liver encymes (&gt; 2x elavated: AST, ALT, bilirubine, PCK) Fibrates are not allowed multiorgantransplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>renal transplantation</keyword>
	<keyword>cardiovasculary disease</keyword>
	<keyword>statin</keyword>
</DOC>